Le. Smeele et al., RADICAL SURGICAL-TREATMENT IN CRANIOFACIAL OSTEOSARCOMA GIVES EXCELLENT SURVIVAL - A RETROSPECTIVE COHORT STUDY OF 14 PATIENTS, European journal of cancer. Part B, Oral oncology, 30B(6), 1994, pp. 374-376
14 patients with an osteosarcoma of the craniofacial bones were evalua
ted retrospectively. 10 patients were males and 4 were females, ages v
aried from 10 to 74 years with a mean of 37 years. Ten tumours were lo
cated in the maxilla and four in the mandible. All patients underwent
surgical resection of the tumour. One patient was irradiated postopera
tively with 67.5 Gy and another patient received adjuvant chemotherapy
with melphelan. Follow-up ranged from 6 months to 10 years with a mea
n of 4 years 2 months. Of 14 patients, 5 have died of local disease of
whom 1 also had distant metastasis. Disease-free survival was 82.5% a
fter 2 years and 68.8% after 5 years. Overall survival was 79.1% after
5 years. Univariate statistical analysis was carried out, revealing a
ge <35 years (P=0.033) and radical surgery (P=0.007) as statistically
significant factors in disease-free survival. It is concluded that rad
ical surgery in young patients with a craniofacial osteosarcoma gives
long-term disease-free survival.